Twist Bioscience CORP Form 4 insider transactions

Emily Leproust, CEO of Twist Bioscience, sold 2,340 shares of common stock on September 6, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Robert F. Werner, Chief Accounting Officer of Twist Bioscience Corp, reports the sale of 813 shares of common stock on August 23, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.

Dennis Cho, a Senior Vice President at Twist Bioscience, sold 709 shares of common stock on August 5, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.

Patrick John Finn, COO of Twist Bioscience, sold 2,885 shares of common stock on August 5, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Twist Bioscience CEO Emily Leproust sold 5,139 shares of common stock on August 5, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.

Paula Green, SVP of Human Resources at Twist Bioscience, sold 1,137 shares of common stock on August 5, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Robert F. Werner, Chief Accounting Officer of Twist Bioscience Corp, sold 168 shares of common stock to cover tax withholding obligations related to vesting Restricted Stock Units.

Patrick John Finn, President and COO of Twist Bioscience, sold 2,207 shares of common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Adam Laponis, CFO of Twist Bioscience, sold 842 shares of common stock on July 9, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Dennis Cho, a Senior Vice President at Twist Bioscience, sold 126 shares of common stock on July 2, 2024, at a price of $48.002 per share to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Emily Leproust, CEO of Twist Bioscience, sold 1,114 shares of common stock to cover tax withholding obligations related to vesting Restricted Stock Units.

Paula Green, SVP of Human Resources at Twist Bioscience, sold 322 shares of common stock on July 2, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Patrick John Finn, COO of Twist Bioscience, sold 476 shares of common stock on July 2, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Emily Leproust, CEO of Twist Bioscience, sold 1,732 shares of common stock on June 20, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Paula Green, SVP of Human Resources at Twist Bioscience, sold 297 shares of common stock on June 20, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Dennis Cho, a Senior Vice President at Twist Bioscience Corp, sold 234 shares of common stock on June 20, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Dennis Cho, a Senior Vice President at Twist Bioscience Corp, sold 95 shares of common stock on June 14, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Dennis Cho, a Senior Vice President at Twist Bioscience, sold 276 shares of common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Robert F. Werner, Chief Accounting Officer of Twist Bioscience Corp, sold 242 shares of common stock on June 6, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Paula Green, SVP of Human Resources at Twist Bioscience, sold 918 shares of common stock on June 6, 2024, at a price of $51.329 per share to cover tax withholding obligations related to vesting Restricted Stock Units.

Emily Leproust, CEO of Twist Bioscience, sold 2,408 shares of common stock to cover tax withholding obligations related to vesting Restricted Stock Units.

Robert F. Werner, Chief Accounting Officer of Twist Bioscience Corp, sold 3,361 shares of common stock on May 23, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.

William Banyai, a Senior Vice President at Twist Bioscience, sold 798 shares of common stock on May 3, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Dennis Cho, a Senior Vice President at Twist Bioscience Corp, sold 568 shares of common stock on May 3, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Paula Green, SVP of Human Resources at Twist Bioscience, sold 910 shares of common stock on May 3, 2024, to cover tax withholding obligations related to vesting Restricted Stock Units.

Emily Leproust, CEO of Twist Bioscience, sold 4,163 shares of common stock on May 3, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Robert F. Werner, Chief Accounting Officer of Twist Bioscience Corp, sold 132 shares of common stock on May 3, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Patrick John Finn, President and COO of Twist Bioscience Corp., sold shares to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Patrick John Finn, President and COO of Twist Bioscience, sold 2,174 shares of common stock on April 23, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Adam Laponis, CFO of Twist Bioscience, sold 556 shares of common stock on April 9, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.